Blog
Clinical trials and pharmaceuticals adapt to growing digital health market
Describing the rise of medical “wearables” in the U.S. and global marketplace as meteoric seems fitting given the rapid growth of the industry over the past decade. Wearable technology has been around for decades (check out an amusing history of some medical and...
Join us for a Kelley School Life Sciences event on February 17
Indiana University’s Kelley School Center for the Business of Life Sciences is hosting a conference titled 2016 Election Effects on Life Sciences and Healthcare. Overview: Now that the winner of the presidential election and composition of the House and Senate has...
Save the date: IMDMC Medical Device event at the Indiana Statehouse February 15, 2017
On February 15, 2017, the Indiana Medical Device Manufacturers Council (IMDMC) will host the annual Medical Device Exhibit and Breakfast at the Indiana Statehouse. This event provides the opportunity to interact with state and federal officials about the industry. To...
New FDA draft guidance points to problems with multiple endpoints in clinical trials
The US FDA released draft guidance this week on the “problems posed by multiple endpoints in the analysis and interpretation of study results and how these problems can be managed in drug and biologic clinical trials,” Zachary Brennan of RAPS reports. The FDA...
21st Century Cures Act: potential impact on the clinical research landscape
The historic 21st Century Cures Act, written into law last December, is a 362-page bill comprised of several initiatives impacting the life sciences industry. The allocation of $4.8 billion for the “Cancer Moonshot” portion of the bill won over most headlines during...